Elevance Health EBITDA 2010-2025 | ELV

Elevance Health annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Elevance Health EBITDA for the quarter ending March 31, 2025 was $3.514B, a 0.59% decline year-over-year.
  • Elevance Health EBITDA for the twelve months ending March 31, 2025 was $10.461B, a 2.17% decline year-over-year.
  • Elevance Health 2024 annual EBITDA was $10.482B, a 0.08% decline from 2023.
  • Elevance Health 2023 annual EBITDA was $10.49B, a 3.59% increase from 2022.
  • Elevance Health 2022 annual EBITDA was $10.126B, a 0.1% increase from 2021.
Elevance Health Annual EBITDA
(Millions of US $)
2024 $10,482
2023 $10,490
2022 $10,126
2021 $10,116
2020 $8,212
2019 $7,866
2018 $6,964
2017 $5,876
2016 $6,190
2015 $6,183
2014 $5,901
2013 $5,497
2012 $5,111
2011 $5,025
2010 $5,374
2009 $8,404
Elevance Health Quarterly EBITDA
(Millions of US $)
2025-03-31 $3,514
2024-12-31 $1,344
2024-09-30 $2,002
2024-06-30 $3,601
2024-03-31 $3,535
2023-12-31 $1,684
2023-09-30 $2,339
2023-06-30 $3,135
2023-03-31 $3,332
2022-12-31 $1,747
2022-09-30 $2,791
2022-06-30 $2,723
2022-03-31 $2,865
2021-12-31 $2,046
2021-09-30 $2,548
2021-06-30 $2,872
2021-03-31 $2,650
2020-12-31 $1,094
2020-09-30 $925
2020-06-30 $3,639
2020-03-31 $2,554
2019-12-31 $1,537
2019-09-30 $1,975
2019-06-30 $1,934
2019-03-31 $2,420
2018-12-31 $1,013
2018-09-30 $1,717
2018-06-30 $1,981
2018-03-31 $2,253
2017-12-31 $798
2017-09-30 $1,493
2017-06-30 $1,614
2017-03-31 $1,971
2016-12-31 $1,068
2016-09-30 $1,538
2016-06-30 $1,860
2016-03-31 $1,724
2015-12-31 $778
2015-09-30 $1,263
2015-06-30 $2,201
2015-03-31 $1,941
2014-12-31 $1,249
2014-09-30 $1,525
2014-06-30 $1,630
2014-03-31 $1,496
2013-12-31 $853
2013-09-30 $1,408
2013-06-30 $1,588
2013-03-31 $1,648
2012-12-31 $819
2012-09-30 $1,346
2012-06-30 $1,348
2012-03-31 $1,598
2011-12-31 $771
2011-09-30 $1,305
2011-06-30 $1,266
2011-03-31 $1,684
2010-12-31 $1,023
2010-09-30 $1,399
2010-06-30 $1,377
2010-03-31 $1,574
2009-12-31 $4,580
2009-09-30 $1,367
2009-06-30 $1,311
2009-03-31 $1,145
Sector Industry Market Cap Revenue
Medical Medical Services $94.057B $177.011B
Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.273B 26.50
CVS Health (CVS) United States $84.883B 10.55
Cencora (COR) United States $56.618B 20.55
Natera (NTRA) United States $21.276B 0.00
DiDi Global (DIDIY) China $19.908B 30.21
BioMerieux (BMXMF) France $15.658B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.897B 0.00
Solventum (SOLV) United States $11.572B 10.79
ICON (ICLR) Ireland $11.550B 10.74
CochLear (CHEOY) Australia $11.542B 0.00
Revvity (RVTY) United States $11.153B 18.83
Doximity (DOCS) United States $11.088B 57.66
Viatris (VTRS) United States $10.187B 3.24
Medpace Holdings (MEDP) United States $8.637B 22.94
Avantor (AVTR) United States $8.606B 12.51
Sonic Healthcare (SKHHY) Australia $8.191B 0.00
HealthEquity (HQY) United States $7.908B 38.90
Charles River Laboratories (CRL) United States $5.866B 11.57
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.018B 23.69
BrightSpring Health Services (BTSG) United States $3.685B 34.11
Sotera Health (SHC) United States $3.667B 20.84
Alignment Healthcare (ALHC) United States $3.063B 0.00
Surgery Partners (SGRY) United States $3.009B 34.51
Concentras Parent (CON) United States $2.767B 14.39
Organon (OGN) United States $2.267B 2.41
Progyny (PGNY) United States $2.005B 44.15
Ardent Health Partners (ARDT) United States $1.880B 0.00
Premier (PINC) United States $1.873B 11.99
GeneDx Holdings (WGS) United States $1.857B 72.70
GoodRx Holdings (GDRX) United States $1.799B 39.08
Agilon Health (AGL) United States $1.702B 0.00
PACS (PACS) United States $1.536B 0.00
Teladoc Health (TDOC) United States $1.254B 0.00
Pediatrix Medical (MD) United States $1.111B 9.32
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.967B 0.00
CareDx (CDNA) United States $0.845B 13.19
AMN Healthcare Services Inc (AMN) United States $0.759B 6.01
Embecta (EMBC) United States $0.724B 4.96
Nutex Health (NUTX) United States $0.720B 14.10
QDM (QDMI) Hong Kong, SAR China $0.583B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 13.67
Sonida Senior Living (SNDA) United States $0.447B 0.00
Enhabit (EHAB) United States $0.404B 37.95
InnovAge Holding (INNV) United States $0.391B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.375B 0.00
LifeMD (LFMD) United States $0.332B 0.00
SBC Medicals (SBC) United States $0.320B 0.00
DocGo (DCGO) United States $0.240B 9.79
Oncology Institute (TOI) United States $0.200B 0.00
Performant Healthcare (PHLT) United States $0.186B 0.00
Beauty Health (SKIN) United States $0.133B 0.00
Sera Prognostics (SERA) United States $0.105B 0.00
Ascend Wellness Holdings (AAWH) United States $0.090B 0.00
So-Young (SY) China $0.085B 0.00
OncoCyte (OCX) United States $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.078B 0.00
Biodesix (BDSX) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Pheton Holdings (PTHL) China $0.025B 0.00
ModivCare (MODV) United States $0.020B 7.05
KindlyMD (KDLY) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00